Surgical Innovations Group appoints Jonathan Glenn to its Board as Senior Independent Director and Chairman-designate

– UK, Leeds –  Surgical Innovations Group Plc (LON: SUN), the designer, manufacturer, and distributor of innovative technology for minimally invasive surgery, today announced the appointment of Jonathan Glenn to its Board as Senior Independent Non-executive Director and Chairman-designate effective immediately.

Jonathan will succeed Nigel Rogers as Chairman in September 2023.

About Jonathan Glenn

Jonathan Glenn is an experienced board director and chairman, with an excellent track record in the medical device sector. He is currently Non-executive Chairman of Tissue Regenix plc and was formerly Group CEO of Consort Medical Plc from 2007 to 2020, where he oversaw the £230m acquisition of a European contract development and manufacturing organization. Jonathan led the business as CEO until its acquisition for £505m in 2020. Jonathan Glenn is a member of the Institute of Chartered Accountants in England and Wales.

He joins the board in anticipation of the upcoming retirement of Professor Mike McMahon, the founder of the Company, who retires from the board at the Annual General Meeting of the Company expected to take place on 27 June 2023.

About Surgical Innovations Group plc

The Group specializes in the design, manufacture, sale, and distribution of innovative, high-quality medical products, primarily for use in minimally invasive surgery. Our product and business development are guided and supported by a key group of nationally and internationally renowned surgeons across the minimally invasive surgical activity spectrum.

We design and manufacture and source our branded port access systems, surgical instruments, and retraction devices which are sold directly in the UK home market through our subsidiary, Elemental Healthcare, and exported widely through a global network of trusted distribution partners. Many of our products in this field are based on a “responsible” concept, in which the products are part reusable, part disposable, offering a high quality and environmentally responsible solution at a cost that is competitive against fully disposable alternatives.

Elemental also has exclusive UK distribution for a select group of specialist products employed in laparoscopy, bariatric and metabolic surgery, hernia repair, and breast reconstruction.

In addition, we design and develop medical devices for carefully selected OEM partners and have collaborated with a major UK industrial partner to provide precision engineering solutions to complex problems outside the medical arena.

We aim for our brands to be recognized and respected by healthcare professionals in all major geographical markets in which we operate and provide by development, partnership, or acquisition a broad portfolio of cost-effective, procedure-specific surgical instruments and implantable devices that offer reliable solutions to genuine clinical needs in the operating theatre environment.


- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.